![Hyun-Soo Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hyun-Soo Kim
Amministratore Delegato presso PHARMICELL CO., LTD.
Patrimonio netto: 28 M $ in data 31/05/2024
Profilo
Hyun-Soo Kim is currently the Chief Executive Officer and Director at Pharmicell Co., Ltd.
He previously worked as Co-CEO, Director, Head-Research & Development at FCB Twelve Co., Ltd.
from 2009 to 2011, and as Chief Executive Officer & Director at FCB-Pharmicell Co., Ltd.
from 2010 to 2011.
He completed his undergraduate degree at Yonsei University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PHARMICELL CO., LTD
10.89% | 29/02/2024 | 6 535 247 ( 10.89% ) | 28 M $ | 31/05/2024 |
Posizioni attive di Hyun-Soo Kim
Società | Posizione | Inizio |
---|---|---|
PHARMICELL CO., LTD. | Amministratore Delegato | 19/08/2009 |
Precedenti posizioni note di Hyun-Soo Kim
Società | Posizione | Fine |
---|---|---|
FCB Twelve Co., Ltd.
![]() FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Presidente | 06/10/2011 |
FCB-Pharmicell Co., Ltd.
![]() FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | Presidente | 27/06/2011 |
Formazione di Hyun-Soo Kim
Yonsei University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHARMICELL CO., LTD. | Health Technology |
Aziende private | 2 |
---|---|
FCB-Pharmicell Co., Ltd.
![]() FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | Commercial Services |
FCB Twelve Co., Ltd.
![]() FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Consumer Non-Durables |
- Borsa valori
- Insiders
- Hyun-Soo Kim